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Site-directed mutagenesis of rat liver S-adenosylmethionine synthetase
Identification of a cysteine residue critical for the oligomeric state
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Instituto de Investigaciones Biome! dicas, CSIC. Arturo Duperier 4, 28029 Madrid, Spain
We have examined the functional importance of the cysteine
residues of rat liver S-adenosylmethionine synthetase. For this
purpose the ten cysteine residues of the molecule were changed to
serines by site-directed mutagenesis. Ten recombinant enzyme
mutants were obtained by using a bacterial expression system.
The same level of expression was obtained for the wild type and
mutants, but the ratio of S-adenosylmethionine synthetase be-
tween soluble and insoluble fractions differed for some of the
mutant forms. The immunoreactivity against an anti-(rat liver S-
adenosylmethionine synthetase) antibody was equivalent in all
the cases. Effects on S-adenosylmethionine synthetase activities
were also measured. Mutants C57S, C69S, C105S and C121S
showed decreased relative specific activity of 68, 85, 63 and 29%,
INTRODUCTION
S-Adenosylmethionine (AdoMet) synthetase (EC 2.5.1.6) is the
enzyme that synthesizes AdoMet using ATP and methionine as
substrates [1]. The importance of this reaction is based on the
fact that AdoMet is the main methyl group donor for the
transmethylation reactions [2]. The rat liver enzyme has been
purified [3,4], cloned [5,6] and expressed in Escherichia coli [7].
Gel-filtration chromatography of the liver-purified and recom-
binant enzymes showed two peaks corresponding to a high-
(210 kDa) and a low-molecular-mass (110 kDa) forms [7]. On
SDS}PAGE both forms showed a unique band of a calculated
molecular-mass of 48 kDa [3]. Based on all these data it has been
concluded that the high-molecular-mass form is a tetramer and
the low-molecular-mass form a dimer composed of the same type
of subunit.
The tetramer}dimer ratio and the activity of liver AdoMet
synthetase have been shown to be altered under several circum-
stances, such as alcohol liver cirrhosis [8], but the mechanisms
that govern these changes are not known. Protein activity and
structure can be modulated by the redox state of some of the
cysteine sulphydryl groups [4]. An important role in this regu-
latory mechanism has been proposed for glutathione, the main
cellular thiol, one of its functions being the protection of protein
sulphydryl groups against oxidation [9]. In fact, enzymes such as
glycogen phosphorylase phosphatase [10], glycogen synthetase
[11], phosphofructokinase [12], 3-hydroxy-3-methylglutaryl-
coenzyme A reductase [13] and rat liver AdoMet synthetase [4]
have been shown to be regulated in itro by the redox system
provided by GSH}GSSG. Moreover, decreases in glutathione
levels by buthionine sulphoximine [14] or carbon tetrachloride
[15] led to a decrease in the AdoMet synthetase activity in rat
liver.
Chemical modification with N-ethylmaleimide (NEM) of the
isolated AdoMet synthetase forms led to a total inactivation of
Abbreviations used: AdoMet, S-adenosylmethionine; NEM, N-ethylmaleimide.
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respectively, compared with wild-type, whereas C312S resulted
in an increase of 1.6-fold. Separation of tetramer and dimer
forms for wild type and mutants was carried out by using
phenyl-Sepharose columns. The dimer}tetramer ratio was calcu-
lated based on the activity and on the protein level estimated by
immunoblotting. No monomeric forms of the enzyme were
detected in any case. Comparison of dimer}tetramer ratios
indicates the importance of cysteine-69 (dimer}tetramer protein
ratio of 88 versus 10.2 in the wild type) in maintaining the
oligomeric state of rat liver S-adenosylmethionine synthetase.
Moreover, all the mutations carried out of cysteine residues
between cysteine-35 and cysteine-105 altered the ratio between
oligomeric forms.
the enzyme when two of the ten sulphydryl groups per subunit
were modified [16]. In addition, modification of these two groups
per subunit produced the dissociation of the tetramer to an
inactive dimer [16]. Moreover, one of these groups seemed to be
responsible for the main activity loss produced. This sulphydryl
group was identified by amino acid analysis of the isolated
peptide as the one corresponding to cysteine-150 of the sequence
[17].
All these data suggested that cysteine sulphydryl groups are
important in the modulation of the activity and oligomeric state
of rat liver AdoMet synthetase. In order to fully establish their
role in the regulation of the enzyme, site-directed mutagenesis of
these residues has been carried out.
EXPERIMENTAL
Materials
Restriction and other DNA-modification enzymes were from
AGS GmbH (Heidelberg, Germany) or from Boehringer
Mannheim (Mannheim, Germany). The Sequenase DNA
sequencing kit was purchased from U.S.B. (Cleveland, OH,
U.S.A.). The thermostable DNA polymerase Dynazyme from
Thermus brockianus was a product of Finnzymes Oy (Espoo,
Finland). [2-$H]ATP was obtained from Amersham (Amersham,
Bucks., U.K.). ATP, methionine, mineral oil, complete and
incomplete Freund’s adjuvants, lysozyme, 2-mercaptoethanol,
aprotinin, pepstatin A, antipain, PMSF and benzamidine were
from Sigma (St. Louis, MO, U.S.A.). Sephadex G-150 and
phenyl-Sepharose CL-4B were purchased from Pharmacia
(Uppsala, Sweden). Chemiluminiscence Renaissance reagents
were obtained from DuPont New England Nuclear (Boston,
MA, U.S.A.). Goat anti-rabbit IgG–horseradish peroxidase and
the Bio-Rad kit I were purchased from Bio-Rad (Hercules, CA,
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U.S.A.). Disposable polypropylene columns were from Pierce
(Rockford, IL, U.S.A.). The rest of the buffers and reagents were
the best quality commercially available.
DNA manipulations
Oligodeoxynucleotides were synthesized on an Applied Bio-
systems 391 DNA synthesizer. DNA manipulations followed
standard procedures [18].
Site-directed mutagenesis
A 1.2 kb fragment containing the rat liver AdoMet synthetase
coding region was amplified by PCR from plasmid pSSRL as
described previously [7] and subcloned into the SmaI site of
pBluescript M13(­)KS (Stratagene, La Jolla, CA, U.S.A.) by
‘TA cloning’ [19]. This plasmid, called pSSRL-BlueT2, was used
as a template for mutagenesis experiments. Site-directed muta-
genesis followed the two-step PCR method of Zhao and
co-workers [20], using the pUC}M13 forward and reverse
primers as external primers, and the following mutagenic oligo-
nucleotides :
5«-ATGGTCAGACAAGCCAT-3« (C9S) ; 5«-CTGGTCAGA-
GATCTTAT-3« (C35S) ; 5«-ACTGTCTCAGAGGCCAC-3«
(C57S) ; 5«-TGTCTTGGACACTGTCT-3« (C61S) ; 5«-ATCTC-
TCCAGACAGGAC-3« (C69S) ; 5«-CACATTGGAGGTCTT-
GA-3« (C105S) ; 5«-ATGGACAGATTGGGCAA-3« (C121S) ;
5«-GCGGCATGGACTCCTCT-3« (C150S) ; 5«-TCTCCGAGA-
GAGCCCAG-3« (C312S) ; 5«-ACCATAGGATGCAGTCT-3«
(C377S). The substituted bases are in italic and all the oligo-
nucleotides are complementary to the coding strand. The cysteine
numbering is the same used in the revised sequence included in
the GenBank}EMBL under the accession number X60822.
The first PCR reactions contained 20 ng of plasmid pSSRL-
BlueT2 as template, 200 ng each of the forward primer and the
mutagenic oligonucleotide, 100 lM dNTPs, 5 ll of 10¬
Dynazyme buffer and 0.5 unit of Dynazyme in a total volume of
50 ll, and the samples were overlaid with 50 ll of mineral oil.
The reactions were carried out in a Gene ATAQ thermal cycler
(Pharmacia) and consisted of a 5 min cycle at 94 °C, followed by
30 cycles at 94 °C for 2 min, 55 °C for 1 min and 72 °C for 1 min,
and ending with 10 min at 72 °C.
For the second PCR, 0.5–1 ll of the first reaction was diluted
in 50 ll of a reaction mixture containing 5 ng of plasmid pSSRL-
BlueT2, 100 lM dNTPs, 5 ll of 10¬ Dynazyme buffer and
0.5 unit of Dynazyme. After elongation of the products of the
first PCR with seven cycles at 94 °C for 1 min, 65 °C for 2 min
and 72 °C for 1 min, 200 ng of each of the external primers,
forward and reverse, were added and the reactions continued for
another 30 cycles at 94 °C for 1 min, 55 °C for 1 min and 72 °C
for 1 min, ending with 10 min at 72 °C. The products of the
second PCR were purified and digested with EcoRI and BamHI
and ligated to the EcoRI}BamHI sites of pBluescript M13(­)KS.
The products of the ligation reactions were used to transform E.
coli DH5a, and 4–6 clones were sequenced using suitable primers
to screen for mutations; typically the efficiency of mutagenesis
was around 75%. The selected mutants were sequenced to
confirm that no additional mutations had been introduced, and
then subcloned into the NdeI}SalI sites of the expression vector
pT7-7 as described previously [7].
Rabbit anti-(AdoMet synthetase) antiserum production
Rat liver AdoMet synthetase purified as described by Pajares and
co-workers [4] was used to immunize New Zealand rabbits.
Figure 1 Characterization of rat liver AdoMet synthetase antiserum
Rat liver AdoMet synthetase antiserum was obtained as described in the Experimental section.
In order to analyse the immune response, immunoblotting of E. coli/pT7-7 (lane 1), E.
coli/pSSRL-T7N (lane 2) and rat liver (lane 3) cytosols were performed. (A) Results obtained
using preimmune antiserum ; and (B) results using the anti-(rat liver AdoMet synthetase)
antiserum.
Preimmune serum was obtained before injection of the antigen.
Enzyme (250 lg) mixed with complete Freund’s adjuvant was
injected in the first immunization. One month later a serum
sample was obtained to test the immune response. At that time,
125 lg of enzyme mixed with incomplete Freund’s adjuvant was
injected, and after 15 days a serum sample was obtained. This
last procedure was repeated twice. The serum obtained after the
last three injections gave a specific response as tested by immuno-
blotting (Figure 1), and the best results were obtained by using
a 1:10000 dilution of the antiserum.
Expression in E. coli and preparation of cell extracts
Wild-type and mutant proteins were expressed in E. coli
BL21(DE3) as described previously [7], except that cells were
disrupted by incubation in lysis buffer [50 mM Tris}HCl (pH 8)}
0.5 M NaCl containing 0.1% 2-mercaptoethanol, 2 lg}ml apro-
tinin, 1 lg}ml pepstatin A, 0.5 lg}ml leupeptin, 2.5 lg}ml anti-
pain, 0.1 mM benzamidine and 0.1 mM PMSF] with 1 mg}ml
lysozyme for 30 min on ice, followed by three cycles of freeze–
thawing in liquid nitrogen.
AdoMet synthetase activity measurements
AdoMet synthetase activity was determined as described pre-
viously [3], using saturating concentrations of each of the
substrates, 5 mM methionine and 5 mM ATP.
Phenyl-Sepharose CL-4B chromatography
For hydrophobic chromatography, 2 ml samples of the cytosolic
fractions obtained from 30 ml cultures were loaded on 5 ml
763The role of cysteine residues in rat liver S-adenosylmethionine synthetase
disposable polypropylene columns containing 1 ml bed volume
of phenyl-Sepharose CL-4B equilibrated in buffer A [10 mM
Hepes}Na (pH 7.5) containing 1 mM EDTA and 10 mM
MgSO
%
]. The sample was eluted with 25 ml of buffer A, followed
by 25 ml of buffer A containing 50% DMSO, and 5 ml fractions
were collected. All the AdoMet synthetase activity appeared in
the first flowthrough fraction and the first DMSO fraction.
Determination of the protein levels by Western-blot analysis
For immunoblot analysis of the soluble protein fractions 5 lg
samples were used. However, for the analysis of the phenyl-
Sepharose eluents 100 ll aliquots (of a total of 5 ml) of the first
flowthrough fraction were lyophilized and dissolved in 20 ll of
SDS}PAGE loading buffer, and 10 ll aliquots (of a total of 5 ml)
of the first DMSO fraction were diluted with 10 ll of the 2¬
loading buffer. These aliquots were loaded on SDS}10% poly-
acrylamide gels and the electrophoresis developed as described
by Laemmli [21]. Proteins were electrotransferred to nitrocel-
lulose membranes using 20 mM Tris}HCl, pH 7.5, containing
20% methanol and the immunoblotting developed using a rabbit
anti-(AdoMet synthetase) antiserum and goat anti-rabbit IgG–
horseradish peroxidase. Protein bands were revealed by chemi-
luminiscence using DuPont New England Nuclear Renaissance
reagents. The films were subjected to densitometric scanning and
the band intensities quantified using the NIH Image v 1.52f
software.
Gel-filtration chromatography
The cytosolic fractions (2 ml each) prepared as described above
were loaded on a Sephadex G-150 column (96 cm¬1.5 cm)
equilibrated in buffer A containing 50 mM KCl, 0.1% 2-
mercaptoethanol, 0.1 mM PMSF and 0.1 mM benzamidine.
Samples were eluted using a flow rate of 12 ml}h and 2 ml
fractions were collected.
Determination of protein concentrations
Protein concentration was measured by the method of Bradford
using the Bio-Rad kit I [22].
RESULTS AND DISCUSSION
Much effort has been directed towards the identification of amino
acid residues essential for enzymic activities. Among these,
cysteines seem to be required for the biological activity of several
proteins as deduced from the results obtained by chemical
modification experiments [23–25]. This type of result has been
also reported for rat liver and E. coli AdoMet synthetases [17,26],
where the NEM modification of two cysteine residues per subunit
led to a total inactivation of the protein.
In order to examine in more detail the role of cysteines in rat
liver AdoMet synthetase, ten enzyme mutants have been
produced. For this purpose the ten cysteine residues present in its
sequence have been substituted individually by serines, using
site-directed mutagenesis. Replacement by serine was decided as
being the most appropriate, since this amino acid is considered to
be isosterical to cysteine and is found to replace cysteine in
corresponding proteins of related organisms with no change
in hydrophobicity [27]. Wild-type and mutant enzymes were
expressed in E. coli in order to analyse the effect of these changes
on the level of expression, activity and oligomeric state ofAdoMet
Figure 2 Soluble wild-type and mutant AdoMet synthetase levels
The cytosolic fractions for each mutant and wild-type (WT) AdoMet synthetase were obtained.
Protein (35 lg) was loaded on SDS/polyacrylamide gels, and the electrophoresis was
performed as described in the Experimental section. The upper panel shows the Coomassie
Brilliant Blue staining of the gel, and the lower panel presents the densitometric scanning of
the band corresponding to AdoMet synthetase. The results shown in the Figure were obtained
from a typical independent experiment out of three.
synthetase. SDS}PAGE of the homogenates showed in all the
cases a new protein band of 48 kDa. In all the cases the expression
level was similar. However, when soluble and insoluble fractions
were separated it was possible to observe that most of the protein
was present in the insoluble pellet (results not shown). The
soluble fraction showed this 48 kDa band in all the cases (Figure
2, upper panel), but its level differed from one mutant to another.
Densitometric scanning of the gel revealed a decrease in the
amount of soluble protein produced in several cases. This
decrease was especially important in two mutants, C57S and
C312S, located relatively close to the N- and C-termini of the
protein respectively. In fact, the amount of soluble protein of
C57S varied from one batch to another. The amounts of
corresponding recombinant proteins present in the soluble frac-
tion were in these cases only 5–10% of that detected in the wild
type (Figure 2, lower panel). A decrease in the amount of soluble
enzyme produced by mutation of certain residues can be due to
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Figure 3 Immunoblotting of the wild-type and mutant AdoMet synthetases
A sample of the soluble fractions of E. coli transformed with wild-type (WT) and mutant AdoMet
synthetases was loaded on SDS/polyacrylamide gels, and the immunoblotting was performed
as described in the Experimental section. The upper panel shows the immunoreactive band and
the lower panel the densitometric scanning of these results. The results shown in the Figure
were obtained from a typical independent experiment out of three.
effects on folding or stability of these proteins, but the con-
tribution to these processes of cysteine residues not involved in
disulphide bonds is not clear [28–31].
To determine if wild-type and mutant AdoMet synthetases
had a similar antigenic character, all the samples were subjected
to immunoblotting using the polyclonal antibody raised against
the purified rat liver enzyme. This antiserum was able to recognize
all the species, wild-type and mutant forms, but failed to react
with E. coli AdoMet synthetase (Figure 1). The migration pattern
of the immunoreactive bands was similar to that of purified rat
liver AdoMet synthetase (Figure 1B). When densitometric scans
from the Coomassie-Brilliant-Blue-stained gels (Figure 2) and
immunoblots (Figure 3) were compared, it was observed that the
antibody recognized all the recombinant AdoMet synthetase
mutants to the same extent. Therefore none of the mutations
appeared to alter dramatically the tertiary structure that the
protein epitopes show on immunoblotting [32]. The intensity of
the C57S band varied between samples of different batches,
since the amount of soluble protein changed, but a correlation
remained between the Coomassie Brilliant Blue staining and the
intensity of the band on immunoblotting.
The effect that mutation of cysteine residues could produce on
the AdoMet synthetase activity was tested using soluble fractions,
and the specific activities obtained are shown inTable 1.However,
since the level of mutant enzymes present in this fraction varied
from one mutant to another, the activity was corrected by the
densitometric scanning of the corresponding AdoMet synthetase
band on Coomassie-Brilliant-Blue-stained gels (Table 1).
Changes of cysteine-57, -69 and -105 decreased the enzyme’s
relative specific activity. This decrease was especially important
for C69S, where only 15% of the wild-type activity was detected.
Table 1 Specific activity of wild-type and mutant AdoMet synthetases
Samples of cytosolic fractions of E. coli transformed with AdoMet synthetase cDNA constructs
corresponding to wild-type and mutant forms were used to measure the enzyme activity as
described in the Experimental section. These cytosolic fractions (35 lg each) were loaded on
SDS/polyacrylamide gels, and the amount of AdoMet synthetase present was determined by
densitometric scanning of the Coomassie-Brilliant-Blue-stained gel. The specific activity was
calculated as pmol/min per mg of protein, and a correction was also made for the amount of
AdoMet synthetase detected and evaluated by densitometry. These corrected values are
expressed as pmol/min per unit of densitometry. The data shown in the table represent the
means³S.E.M. of three independent experiments performed in triplicate.
Specific activity
Enzyme (pmol/min per mg of protein) (pmol/min per unit)
Wild type 13937³1495 2.63³0.09
C9S 13422³720 2.38³0.09
C35S 7896³613 2.09³0.09
C57S 771³300 0.85³0.09
C61S 10139³748 2.09³0.08
C69S 2871³645 0.39³0.09
C105S 4827³981 0.96³0.12
C121S 9530³686 1.87³0.09
C150S 9050³400 2.91³0.09
C312S 4281³336 4.22³0.11
C377S 8948³668 2.07³0.09
On the other hand, substitution of cysteine-312 increased the
relative specific activity 1.6-fold. Replacement of key residues for
protein function by other amino acids is expected to produce
changes in the activity and}or affinity of these mutants [28,33,34].
In our case several mutants showed decreased relative specific
activity, but none of these changes completely abolished the
activity, as would be expected for a residue directly implicated in
catalysis. The most surprising result concerned C150S, the residue
implicated in the inactivation of rat liver AdoMet synthetase by
NEM modification [17]. This mutant showed no change in the
relative specific activity compared with the wild-type enzyme.
Table 2 Dimer/tetramer activity ratio in wild-type and mutant AdoMet
synthetases
Dimer and tetramer forms of wild-type and mutant AdoMet synthetases were separated by
phenyl-Sepharose chromatography as described in the Experimental section. Fractions
corresponding to each enzyme form were assayed to determine the dimer/tetramer activity ratio.
The data shown in the table represent the means³S.E.M. of three independent experiments
performed in triplicate.
Enzyme Activity ratio
Wild type 2.80³0.44
C9S 3.97³0.49
C35S 4.11³0.45
C57S 0.99³0.43
C61S 2.99³0.38
C69S 4.08³0.84
C105S 4.86³2.43
C121S 10.09³2.57
C150S 3.27³1.32
C312S 1.49³0.27
C377S 2.94³0.67
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This type of result has been obtained in several proteins when the
data derived from chemical modifications were re-examined by
site-directed mutagenesis, among them Drosophila alcohol de-
hydrogenase [35] and E. coli AdoMet synthetase [36]. The steric
constraints due to NEM modification [17] were not expected to
be the same as those due to amino acid substitution. However,
we cannot rule out the location of a non-essential thiol near the
binding site in those cases where protection by the substrates
against chemical modification has been shown [17,26,36,37].
It is well known that rat liver AdoMet synthetase and the
recombinant wild-type enzyme in E. coli appear as tetramers and
dimers [3,7]. Previous studies by NEM modification [17] and
GSSG incubation [4] have indicated a possible role for cysteine
residues in maintaining the oligomeric state. To study this
possibility, the amount of each oligomeric form was studied for
each mutant using phenyl-Sepharose CL-4B, which is a pro-
cedure that gives better resolution of tetramers and dimers
[38–40]. The high-molecular-mass form does not bind to this type
of gel, whereas the dimer binds tightly and can only be eluted in
the presence of 50% DMSO. The soluble fraction of wild-type
and mutant AdoMet synthetases was loaded on phenyl-
Sepharose columns, and both oligomeric forms were separated.
Once isolated, the activity of the tetramer and dimer forms was
measured, and the amount of each protein was evaluated by
immunoblotting. Several alterations in the ratio of dimer}
tetramer activities were observed (Table 2). C57S and C312S
showed a lower ratio, with approximately equal activity for both
oligomeric forms. On the other hand, C121S showed a much
higher ratio, where dimer activity was about 10-fold higher than
that of the tetramer. Other mutants, C9S, C35S, C69S and
C105S, also had an altered dimer}tetramer ratio showing higher
dimer activity (about 4-fold). These data must be interpreted
bearing in mind several parameters : first, elution of the dimer in
the presence of DMSO leads to a slight activation of this form,
even when the assay is carried out under saturating concen-
trations of methionine [3,39]. Secondly, E. coli presents its own
AdoMet synthetase, which appears as a tetramer [41] and which
on phenyl-Sepharose chromatography behaves like the recom-
binant tetramer. Therefore, it is conceivable that the total and
tetramer activities measured would be a mixture of both AdoMet
synthetases. Thirdly, the exact contribution of the bacterial
tetramer cannot be evaluated without the separation of both.
However, it is not expected to be very important since E. coli
AdoMet synthetase expression and activity is regulated by
AdoMet, which acts as a co-repressor [42] and an inhibitor
Figure 5 Scheme of the localization of the cysteine residues present in several AdoMet synthetase sequences
All the sequences were obtained from Genbank and aligned using programs from the GCG package.
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Figure 4 Dimer/tetramer ratio evaluated by immunoblotting
Dimer (D) and tetramer (T) forms of wild-type (WT) and mutant AdoMet synthetases were
separated by phenyl-Sepharose chromatography as described in the Experimental section.
Samples of tetramer (protein corresponding to 100 ll) and dimer (protein present in 10 ll)
fractions were loaded on SDS/polyacrylamide gels, and the immunoblotting was performed. The
upper panel shows bands obtained on immunoblotting and the lower panel the densitometric
scans of the dimer/tetramer ratio. The results shown in the Figure were obtained from a typical
independent experiment out of three.
respectively, even at lower concentrations than the ones detected
in the wild-type transformed bacteria (millimolar range) [7].
When the ratio between AdoMet synthetase forms was studied
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by immunoblotting, several changes were also observed com-
pared with the wild type (Figure 4). Higher dimer}tetramer
ratios were detected in C69S, C312S and C377S, especially C69S,
which showed most of the protein as a dimer. On the other hand,
C35S, C57S, C61S and C105S showed a lower ratio, approxi-
mately twice dimer to tetramer. The possible presence of the
mutant enzymes as monomer forms was also studied using
Sephadex G-150 columns. None of the enzymes showed activity
or the presence of AdoMet synthetase immunoreactive bands as
judged by immunoblotting of the fractions eluting in the region
expected for monomer recovery (results not shown). All these
data indicate changes in the dimer}tetramer ratio in several
mutant enzymes, the most important ones being those related to
the area between cysteine residues 35 and 105. The most dramatic
of these is C69S, whose mutated residue is located in the most
hydrophobic area of theAdoMet synthetase molecule as observed
in a hydrophobicity profile [43], as would be expected for a
residue implicated in subunit interactions.
Changes in the oligomeric state upon mutation of key cysteine
residues have been reported previously [44,45]. In fact, mutation
of cysteine-90 of E. coli AdoMet synthetase (C90S and C90A) led
to the appearance of dimers [36]. These results would support the
idea that the corresponding rat liver AdoMet synthetase residue
(cysteine-105) would play the same role in the subunit interaction;
however, the most dramatic change is obtained by replacement
of another residue, in C69S.
Finally, the replaced cysteine residues present in all the known
sequences of AdoMet synthetases, C57S and C105S (Figure 5),
are not the ones producing the most important changes either in
activity or oligomeric state. This role is reserved for that in C69S,
a residue typical of rat, mouse and human liver enzymes (Figure
5). It is also noteworthy that rat and human liver are the tissues
that present AdoMet synthetase in two oligomeric forms, dimer
and tetramer [3,8]. Other cysteine residues present only in hepatic
AdoMet synthetases (cysteine-9 and cysteine-377) do not produce
such changes. Therefore it is possible to deduce that cysteine-69
is the residue implicated in the distribution of oligomeric forms
observed in liver AdoMet synthetase. Moreover, all the mutations
carried out of the cysteine residues between cysteine-35 and
cysteine-105 alter the ratio between oligomeric forms. Altogether,
these results suggest the involvement of this area in binding
between subunits. Kinetic and crystallographic studies of the
purified mutant and wild-type enzymes may yield further insight
into interactions involved in protein oligomerization.
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